Skip to content
cccskills
FreePublished on GitHub

jes-pa-avs-bypass-unilateral

Identifies young patients with classic primary aldosteronism features who may proceed directly to unilateral adrenalectomy without adrenal venous sampling based on high probability of unilateral disease. Triggered when a clinician sees a patient <35 years with hypokalemia, unilateral adrenal tumor on CT, and high plasma aldosterone concentration and asks whether AVS can be bypassed.

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.4 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Determine when AVS can be bypassed for suspected unilateral PA

STEP 1 — Gather Information

Collect age, serum potassium, plasma aldosterone concentration (PAC), and adrenal CT to assess for unilateral adrenal tumor.

STEP 2 — Rule In / Rule Out

Is the patient younger than 35 years? If no, proceed to adrenal venous sampling (AVS) for lateralization (cannot bypass). If yes, continue to evaluate for hypokalemia, high PAC, and unilateral tumor.

STEP 3 — Classify or Stratify

Among patients <35 years, assess for serum potassium <3.5 mEq/L, PAC >300 pg/mL, and unilateral adrenal tumor on CT. If all three are present, classify as high probability unilateral PA and eligible for AVS bypass; if any criterion is missing, classify as needing AVS.

STEP 4 — Decide

If classified as high probability unilateral PA, proceed to unilateral adrenalectomy after obtaining informed consent; otherwise, perform AVS to lateralize disease before deciding on surgery or medical therapy.

Clinical Guardrails / Mimics / Pitfalls

Do not bypass AVS in patients aged 35 years or older, with normokalemia (K+ ≥3.5 mEq/L), PAC ≤300 pg/mL, bilateral or absent adrenal lesions on CT, or when autonomous cortisol co‑secretion is suspected (requires dexamethasone suppression test). Avoid bypass if patient declines surgery or has high surgical risk; AVS remains gold standard for subtype diagnosis when certainty is low.

Concrete Clinical Example

A 32‑year‑old woman with hypertension presents with spontaneous hypokalemia (K+ 3.0 mEq/L), PAC 350 pg/mL, and a 1.2 cm left adrenal nodule on CT without contralateral lesion. She meets all criteria (<35 y, hypokalemia, high PAC, unilateral tumor) and, after informed consent, undergoes left laparoscopic adrenalectomy without prior AVS.

Source: Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021, Japan Endocrine Society, 2021

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill